Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

Award

Value

£105,600

Classifications

  • Pharmaceutical products

Tags

  • award

Submission Deadline

11 months ago

Published

10 months ago

Description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo.

Additional information: 
Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete